{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:51:30Z","timestamp":1761929490624},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,29]],"date-time":"2010-05-29T00:00:00Z","timestamp":1275091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10238-010-0101-x","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T13:47:55Z","timestamp":1275054475000},"page":"55-59","source":"Crossref","is-referenced-by-count":9,"title":["Rapid and sensitive allele-specific (AS)-RT-PCR assay for detection of T315I mutation in chronic myeloid leukemia patients treated with tyrosine-kinase inhibitors"],"prefix":"10.1007","volume":"11","author":[{"given":"Gonzalo","family":"Manrique Arechavaleta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Moellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor N.","family":"Seu\u00e1nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Dobbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lem","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana Zalcberg","family":"Renault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Uriarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,29]]},"reference":[{"key":"101_CR1","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1182\/blood-2008-06-162388","volume":"112","author":"D Marin","year":"2008","unstructured":"Marin D, Milojkovic D, Olavarria E, Khorashad JS, de Lavallade H, Reid AG, Foroni L, Rezvani K, Bua M, Dazzi F, Pavlu J, Klammer M, Kaeda JS, Goldman JM, Apperley JF (2008) European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor. Blood 112:4437\u20134444","journal-title":"Blood"},{"key":"101_CR2","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2004-03-1134","volume":"104","author":"S Branford","year":"2004","unstructured":"Branford S, Rudzki Z, Parkinson I, Grigg A, Taylor K, Seymour JF, Durrant S, Browett P, Schwarer AP, Arthur C, Catalano J, Leahy MF, Filshie R, Bradstock K, Herrmann R, Joske D, Lynch K, Hughes T (2004) Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations. Blood 104:2926\u20132932","journal-title":"Blood"},{"key":"101_CR3","doi-asserted-by":"crossref","unstructured":"Branford S (2007) Chronic myeloid leukemia: molecular monitoring in clinical practice. Hematology Am Soc Hematol Educ Program Book 376\u2013383","DOI":"10.1182\/asheducation-2007.1.376"},{"key":"101_CR4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood-2007-09-110189","volume":"15","author":"H Kantarjian","year":"2008","unstructured":"Kantarjian H, Schiffer C, Jones D, Cortes J (2008) Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods. Blood 15:1774\u20131779","journal-title":"Blood"},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CCO.0b013e3282f1fe8a","volume":"20","author":"D Milojkovic","year":"2008","unstructured":"Milojkovic D, Apperley J (2008) State-of-the-art in the treatment of chronic myeloid leukaemia. Curr Opin Oncol 20:112\u2013121","journal-title":"Curr Opin Oncol"},{"key":"101_CR6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","volume":"102","author":"S Branford","year":"2003","unstructured":"Branford S, Rudzki Z, Walsh S, Parkinson I, Grigg A, Szer J, Taylor K, Herrmann R, Seymour JF, Arthur C, Joske D, Lynch K, Hughes T (2003) Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood 102:276\u2013283","journal-title":"Blood"},{"key":"101_CR7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/clinchem\/46.12.1929","volume":"46","author":"SJ Clayton","year":"2000","unstructured":"Clayton SJ, Scott FM, Walker J, Callaghan K, Haque K, Liloglou T, Xinarianos G, Shawcross S, Ceuppens P, Field JK, Fox JC (2000) K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem 46:1929\u20131938","journal-title":"Clin Chem"},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","volume":"108","author":"M Baccarani","year":"2006","unstructured":"Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R (2006) Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 108:1809\u20131820","journal-title":"Blood"},{"key":"101_CR9","unstructured":"Scholl V, Bitencourt R, Pires V, Padilha T, Hassan R, Zalcberg IR (2008) Measurement of BCR-ABL transcripts in long-term allogeneic stem cell transplantation CML patients by real-time quantitative PCR (RQ-PCR). Haematologica 93(S1):540\u2013541"},{"key":"101_CR10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10428190009057647","volume":"37","author":"IB Otaz\u00fa","year":"2000","unstructured":"Otaz\u00fa IB, Zalcberg I, Tabak DG, Dobbin J, Seu\u00e1nez HN (2000) Detection of BCR-ABL transcripts by multiplex and nested PCR in different haematological disorders. Leuk Lymphoma 37:205\u2013211","journal-title":"Leuk Lymphoma"},{"key":"101_CR11","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V99.9.3472","volume":"99","author":"S Branford","year":"2002","unstructured":"Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K, Herrmann R, Lynch KP, Hughes TP (2002) High frequency of point mutations clustered within the adenosine triphosphate binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood 99:2475\u20133472","journal-title":"Blood"},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2005-03-1036","volume":"106","author":"SG Willis","year":"2005","unstructured":"Willis SG, Lange T, Demehri S, Otto S, Crossman L, Niederwieser D, Stoffregen EP, McWeeney S, Kovacs I, Park B, Druker BJ, Deininger MW (2005) High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy. Blood 106:2128\u20132137","journal-title":"Blood"},{"key":"101_CR13","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2007-03-066936","volume":"110","author":"T O\u2019Hare","year":"2007","unstructured":"O\u2019Hare T, Eide CA, Deininger MW (2007) Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 110:2242\u20132249","journal-title":"Blood"},{"key":"101_CR14","unstructured":"Soverini S, Poerio A, Vitale A, Gnani A, Colarossi S, Castagnetti F, Iacobucci I, Lonetti A, Palandri F, Rosti G, Amabile M, Paolini S, Papayannidis C, Gugliotta G, Vignetti M, Mandelli F, Baccarani M, Fo\u00e0 R, Martinelli G (2009) At the time of diagnosis, Ph\u00a0+\u00a0cells from both chronic phase myeloid leukemia and acute lymphoblastic leukemia patients already harbour BCR-ABL kinase domain mutations. Haematologica 94(suppl.2):212 (abs. 0526)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-010-0101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-010-0101-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-010-0101-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T04:43:02Z","timestamp":1591332182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-010-0101-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,29]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s10238-010-0101-x","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,29]]}}}